Cargando…
Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders
Abnormalities in the integral components of bone, including bone matrix, bone mineral and bone cells, give rise to complex disturbances of skeletal development, growth and homeostasis. Non-specific drug delivery using high-dose systemic administration may decrease therapeutic efficacy of drugs and i...
Autores principales: | Dang, Lei, Liu, Jin, Li, Fangfei, Wang, Luyao, Li, Defang, Guo, Baosheng, He, Xiaojuan, Jiang, Feng, Liang, Chao, Liu, Biao, Badshah, Shaikh Atik, He, Bing, Lu, Jun, Lu, Cheng, Lu, Aiping, Zhang, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813278/ https://www.ncbi.nlm.nih.gov/pubmed/27011176 http://dx.doi.org/10.3390/ijms17030428 |
Ejemplares similares
-
Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems
por: Jiang, Feng, et al.
Publicado: (2015) -
Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma
por: Shaikh, Atik Badshah, et al.
Publicado: (2016) -
Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer
por: Liu, Jin, et al.
Publicado: (2017) -
In Vivo Delivery Systems for Therapeutic Genome Editing
por: Wang, Luyao, et al.
Publicado: (2016) -
Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis
por: He, Xiaojuan, et al.
Publicado: (2019)